ESMO Immuno-Oncology Congress 2019: Programme

The ESMO Immuno-Oncology Congress 2019 programme is now online!

The ESMO Immuno-Oncology Congress is an annual event devoted entirely to the development and use of the immunotherapies against cancer. It provides a comprehensive overview of everything you need to know in this fast-moving field, from recent advances to those in the pipeline.

Delegates at the ESMO Immuno-Oncology Congress 2019 now also have the opportunity to take part in a special primer taking place prior to the Congress, on 10 December.

The primer, organized by the Society for Immunotherapy of Cancer (SITC) and ESMO, will provide education on introductory immunology and immunotherapy.

View the online programme


ESMO-MORA: The ESMO Immuno-Oncology Congress 2019 programme has been accredited with 25 category 1 ESMO-MORA points​. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See  here for further details.


All Speakers and Discussants are required to declare their interests, if any, and include a Declaration of Interest (DOI) slide at the start of their presentation(s).

The experts invited by ESMO as Discussants are selected on an individual basis to provide their own interpretation of the data and are not acting as ESMO spokespersons.

The ESMO recommendations on the clinical utility of new drugs are only presented in the ESMO Clinical Practice Guidelines and such recommendations represent the only official position of ESMO.


The Congress webcasts will include all the sessions of the official programme, where speaker permission is granted, and will be available on this website and on OncologyPRO for ESMO members.